Back to Results
First PageMeta Content
Immunosuppressants / Arthritis / Pharmacology / Amgen / Etanercept / Rheumatoid arthritis / Tumor necrosis factor-alpha / Biologic / Placebo / Medicine / Health / Biology


~~~ sERVICES Public Health Service DEPARTMENT OF HEALTH & HUMAN SERVICES
Add to Reading List

Open Document

File Size: 2,16 MB

Share Result on Facebook

City

Rockville / Lincoln / /

Company

JUt 14 ZIJO3 Immunex Corporation / /

Event

FDA Phase / /

Facility

American College of Rheumatology / Rockville Pike / /

IndustryTerm

proposed introductory advertising / Final printed advertising / /

MedicalCondition

tumor necrosis factor receptor / polyarticular-course juvenile rheumatoid arthritis / inflammatory processes / ankylosing spondylitis / RA psoriatic arthritis / arthritis / rheumatoid arthritis / RA disease / tumor necrosis factor / normal inflammatory and immune responses / inflammation / /

Organization

Food and Drug Administration / ID PCS / ID SC / M. Acting Director Division of Clinical Trials Design / Review Center for Drug Evaluation and Research Enclosures / American College of Rheumatology / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH / office of Therapeutics Research / Center for Biologics Evaluation and Research / Pharmacokinetics After administration / /

Person

Patricia Keegan / Douglas Hunt / Package Insert / /

Position

Physician global assessment / Physician / Major / Director / Regulatory Affairs One Amgen Center Drive Mail Stop 24Thousand Oaks / CLINICAL PHARMACOLOGY General / AS Physician / /

Product

SC / ENBREL / sulfasalazine / MTX tablets / Bacteriostatic Water for Injection / azathioprine / mannitol / HFM-224 / Etanercept / /

ProvinceOrState

Maryland / California / /

Technology

alpha / Pharmacokinetics / http / html / recombinant DNA technology / PDF / /

SocialTag